News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Cuts ALI HEALTH (00241.HK) TP to $4.8 w/ Rating Neutral, Expects AI Investment to Weigh on Profits
Goldman Sachs issued a research report cutting its target price for ALI HEALTH (00241.HK) from $5.2 to $4.8, with rating at Neutral, to reflect the impact of increased investment i...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Cuts ALI HEALTH (00241.HK) TP to $4.8 w/ Rating Neutral, Expects AI Investment to Weigh on Profits
Close
Recommend
13
Positive
14
Negative
10
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Goldman Sachs issued a research report cutting its target price for ALI HEALTH (00241.HK)  -0.010 (-0.215%)    Short selling $125.18M; Ratio 32.989%   from $5.2 to $4.8, with rating at Neutral, to reflect the impact of increased investment in AI and pharmaceutical categories on profitability.

ALI HEALTH's share price has only fallen 3% YTD, outperforming the HSTECH's 11% decline, mainly supported by growth expectations and the potential of AI healthcare, the report added.

Related NewsCLSA Cuts ALIBABA HEALTH INFORMATION TECHNOLOGY (00241.HK) TP to HKD5.3, Rates Outperform
However, the broker projected the Company's 2H26 profit to drop slightly, reversing the profit expansion trend in 1H26, primarily due to higher investment in AI initiatives and more discounts on original drugs to cope with competition. AI investment is estimated to continue through FY2027.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-10 16:25.)

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.